Skip to contentT
TuHURA Biosciences, Inc.
T
HURATuHURA Biosciences, Inc. Source filing unavailable
Q2 2024 · —
Revenue$0.00$0.00derivedno prior Q2 2023 on file Net Income-$5.27M-$5.27Mno prior Q2 2023 on file EPS Diluted-$0.43-$0.43no prior Q2 2023 on file Operating Cash Flowderived-$5,065,808— The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TuHURA Biosciences, Inc. · CIK 1498382 · Engraved from SEC EDGAR